Pathogens identified in the internal tissues and placentas of stillbirths: results from the prospective, observational PURPOSe study
- PMID: 37069731
- DOI: 10.1111/1471-0528.17479
Pathogens identified in the internal tissues and placentas of stillbirths: results from the prospective, observational PURPOSe study
Abstract
Objective: To examine internal organ tissues and placentas of stillbirths for various pathogens.
Design: Prospective, observational study.
Settings: Three study hospitals in India and a large maternity hospital in Pakistan.
Population: Stillborn infants delivered in a study hospital.
Methods: A prospective observational study.
Main outcome measures: Organisms identified by pathogen polymerase chain reaction (PCR) in internal organs and placental tissues of stillbirths.
Results: Of 2437 stillbirth internal tissues, 8.3% (95% CI 7.2-9.4) were positive. Organisms were most commonly detected in brain (12.3%), cerebrospinal fluid (CSF) (9.5%) and whole blood (8.4%). Ureaplasma urealyticum/parvum was the organism most frequently detected in at least one internal organ (6.4% of stillbirths and 2% of all tissues). Escherichia coli/Shigella was the next most common (4.1% one or more internal organ tissue sample and 1.3% of tissue samples), followed by Staphylococcus aureus in at least one internal organ tissue (1.9% and 0.9% of all tissues). None of the other organisms was found in more than 1.4% of the tissue samples in stillbirths or more than 0.6% of the internal tissues examined. In the placenta tissue, membrane or cord blood combined, 42.8% (95% CI 40.2-45.3) had at least one organism identified, with U. urealyticum/parvum representing the most commonly identified (27.8%).
Conclusions: In about 8% of stillbirths, there was evidence of a pathogen in an internal organ. Ureaplasma urealyticum/parvum was the most common organism found in the placenta and in the internal tissues, especially in the fetal brain.
Keywords: India; PCR; Pakistan; infection; minimall invasive tissue sampling; placenta; stillbirth.
© 2023 John Wiley & Sons Ltd.
References
REFERENCES
-
- McClure EM, Saleem S, Pasha O, Goldenberg RL. Stillbirth in developing countries: a review of causes, risk factors and prevention strategies. J Matern Fetal Neonatal Med. 2009;22(3):183-90.
-
- McClure EM, Saleem S, Goudar SS, Garces A, Whitworth R, Esamai F, et al. Stillbirth 2010-2018: a prospective, population-based, multi-country study from the global network. Reprod Health. 2020;17(Suppl 2):146.
-
- Saleem S, Tikmani SS, McClure EM, Moore JL, Azam SI, Dhaded SM, et al. Trends and determinants of stillbirth in developing countries: results from the global Network's population-based birth registry. Reprod Health. 2018;15(Suppl 1):100.
-
- Lawn JE, Blencowe H, Waiswa P, Amouzou A, Mathers C, Hogan D, et al. Lancet ending preventable stillbirths series study group; lancet stillbirth epidemiology investigator group. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet. 2016;387(10018):587-603.
-
- Hug L, You D, Blencowe H, Mishra A, Wang Z, Fix MJ, et al. Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment. Lancet. 2021;398(10302):772-85.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
